Aptabio Therapeutics Inc. operates pharmaceutical production businesses. The Company produces anticancer drugs and other pharmaceutical products. Aptabio Therapeutics conducts businesses in Korea.

Material Management Information related to Judgment of Investment(Application for IND Approval)(APX115(Isuzinaxib)ì ì  2bì ìììíê³í ì¹ì¸ì ì²­(IND))

Other Management Information(Voluntary Disclosure)(ì íì°ì ì£¼ì ë³´íµì£¼ ì íì²­êµ¬)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

AptaBio Therapeutics (293780 KS)

Material Management Information related to Judgment of Investment(Application for IND Approval)(APX115(Isuzinaxib)ì ì 2bì ìììíê³í ì¹ì¸ì ì²(IND))

Other Management Information(Voluntary Disclosure)(ì íì°ì ì£¼ì ë³´íµì£¼ ì íì²êµ¬)

Decision on Acquisition of Shares or Investment Securities of Other Corporation

[Revised] Submission of Audit Report

Outcomes of Annual Meeting of Shareholders

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Material Management Information related to Judgment of Investment(Application for IND Approval)(APX115(Isuzinaxib)ì ì  2bì ìììíê³í ì¹ì¸ì ì²­(IND))

Other Management Information(Voluntary Disclosure)(ì íì°ì ì£¼ì ë³´íµì£¼ ì íì²­êµ¬)

Decision on Acquisition of Shares or Investment Securities of Other Corporation

[Revised] Submission of Audit Report

Outcomes of Annual Meeting of Shareholders

Material Management Information related to Judgment of Investment(Application for IND Approval)(APX115(Isuzinaxib)ì ì 2bì ìììíê³í ì¹ì¸ì ì²(IND))

Other Management Information(Voluntary Disclosure)(ì íì°ì ì£¼ì ë³´íµì£¼ ì íì²êµ¬)